Literature DB >> 10391675

Cell-cycle-dependent and ATM-independent expression of human Chk1 kinase.

Y S Kaneko1, N Watanabe, H Morisaki, H Akita, A Fujimoto, K Tominaga, M Terasawa, A Tachibana, K Ikeda, M Nakanishi, Y Kaneko.   

Abstract

Checkpoint genes cause cell cycle arrest when DNA is damaged or DNA replication is blocked. Although a human homolog of Chk1 (hChk1) has recently been reported to be involved in the DNA damage checkpoint through phosphorylation of Cdc25A, B, and C, it is not known at which phase(s) of the cell cycle hChk1 functions and how hChk1 causes cell cycle arrest in response to DNA damage. In the present study, we demonstrate that in normal human fibroblasts (MJ90), hChk1 is expressed specifically at the S to M phase of the cell cycle at both the RNA and protein levels and that it is localized to the nucleus at this time. hChk1 activity, as determined by phosphorylation of Cdc25C, is readily detected at the S to M phase of the cell cycle, and DNA damage induced by UV or ionizing radiation does not enhance the expression of hChk1 or its activity. Furthermore, hChk1 exists in an active form at the S to M phase in fibroblasts derived from patients with ataxia telangiectasia (AT) which lack the functional AT mutated (ATM) gene product, suggesting that hChk1 expression is independent of functional ATM. Taken together with the findings that phosphorylation of Cdc25C on serine 216 is increased at the S to M phase, it is suggested that at this particular phase of the cell cycle, even in the absence of DNA damage, hChk1 phosphorylates Cdc25C on serine 216, which is considered to be a prerequisite for the G2/M checkpoint. Thus, hChk1 may play an important role in keeping Cdc25C prepared for responding to DNA damage by phosphorylating its serine residue at 216 during the S to M phase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10391675     DOI: 10.1038/sj.onc.1202706

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  48 in total

1.  p53 down-regulates CHK1 through p21 and the retinoblastoma protein.

Authors:  V Gottifredi; O Karni-Schmidt; S S Shieh; C Prives
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  Radiation-induced phosphorylation of Chk1 at S345 is associated with p53-dependent cell cycle arrest pathways.

Authors:  Hui Tian; Alexander T Faje; Siu Lan Lee; Timothy J Jorgensen
Journal:  Neoplasia       Date:  2002 Mar-Apr       Impact factor: 5.715

Review 3.  Global regulation of genome duplication in eukaryotes: an overview from the epifluorescence microscope.

Authors:  John Herrick; Aaron Bensimon
Journal:  Chromosoma       Date:  2008-01-16       Impact factor: 4.316

4.  A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpoint.

Authors:  Rachel Beckerman; Aaron J Donner; Melissa Mattia; Melissa J Peart; James L Manley; Joaquin M Espinosa; Carol Prives
Journal:  Genes Dev       Date:  2009-06-01       Impact factor: 11.361

5.  Distinct mechanisms act in concert to mediate cell cycle arrest.

Authors:  Jared E Toettcher; Alexander Loewer; Gerard J Ostheimer; Michael B Yaffe; Bruce Tidor; Galit Lahav
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-12       Impact factor: 11.205

6.  Role of Chk1 in the differentiation program of hematopoietic stem cells.

Authors:  Laura Carrassa; Elisa Montelatici; Lorenza Lazzari; Stefano Zangrossi; Matteo Simone; Massimo Broggini; Giovanna Damia
Journal:  Cell Mol Life Sci       Date:  2010-02-10       Impact factor: 9.261

Review 7.  S-phase-coupled apoptosis in tumor suppression.

Authors:  Yong-Jig Cho; Peng Liang
Journal:  Cell Mol Life Sci       Date:  2011-03-25       Impact factor: 9.261

Review 8.  Roles of Chk1 in cell biology and cancer therapy.

Authors:  Youwei Zhang; Tony Hunter
Journal:  Int J Cancer       Date:  2013-05-28       Impact factor: 7.396

9.  Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activity.

Authors:  M Walker; E J Black; V Oehler; D A Gillespie; M T Scott
Journal:  Oncogene       Date:  2009-05-04       Impact factor: 9.867

10.  MEPE/OF45 protects cells from DNA damage induced killing via stabilizing CHK1.

Authors:  Shuang Liu; Hongyan Wang; Xiang Wang; Lin Lu; Ning Gao; Peter S N Rowe; Baocheng Hu; Ya Wang
Journal:  Nucleic Acids Res       Date:  2009-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.